Connect Biopharma Holdings (CNTB) Other Non-Current Liabilities (2024 - 2026)

Connect Biopharma Holdings has disclosed Other Non-Current Liabilities across 3 years of filings, most recently posting $107000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities fell 12.3% year-over-year to $107000.0; the TTM figure through Jun 2026 stood at $107000.0 (down 12.3% YoY), while the FY2025 annual figure was $114000.0, down 81.96% from the prior year.
• Other Non-Current Liabilities came in at $107000.0 for Q2 2026 at Connect Biopharma Holdings, down from $111000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $632000.0 in Q4 2024 to a low of $107000.0 in Q2 2026.
• Average Other Non-Current Liabilities over 3 years is $261571.4, with a median of $118000.0 recorded in 2025.
• The largest YoY upside for Other Non-Current Liabilities was 12.3% in 2026 against a maximum downside of 82.3% in 2026.
• Over 3 years, Other Non-Current Liabilities stood at $632000.0 in 2024, then tumbled by 81.96% to $114000.0 in 2025, then slipped by 6.14% to $107000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $107000.0 in Q2 2026, $111000.0 in Q1 2026, and $114000.0 in Q4 2025.